HIV Life Cycle

T22

From U.S. National Institute of Allergy and Infectious Diseases

In-vitro Data
Cell	Strain	EC50	IC50	Units	TI	Reference
MT-4	HIV-1(IIIB)	0.008	54	ug/mL	6750	1

References

Masuda,M.; Nakashima,H.; Ueda,T.; Naba,H.; Ikoma,R.; Otaka,A.; Terekawa,Y. Tamamura,H.; Ibuka,T.; Murakami,T.; Koyanagi,Y.; Waki,M.; Matsumoto,A.; Yamamoto,N.; Funakoshi,S.; Fujii,N., A novel anti-hiv synthetic peptide, T-22([TYR^5,12,LYS^7]- Polyphemusin II). BIOCHEM BIOPHYS RES COMMUN 189(2):845-850 (1992).

Back

This article was provided by U.S. National Institute of Allergy and Infectious Diseases.

10 Questions to Ask Yourself Before You Begin HIV Treatment

Getting to Undetectable: People Living With HIV Share Their Stories

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Let's Talk About the HIV Cure News: A Blog Entry by Warren Tong

Get TheBody.com in the Palm of Your Hand

More >>

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.

HIV Life Cycle

In-vitro Data

References